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1. Introduction
   A large portion of the world population, especially in 
developing countries depends on the traditional system of 
medicine against a variety of diseases. Several hundred 
genera are used medicinally, mainly as herbal preparations 
in the indigenous systems of medicine in different countries 
and are sources of very potent and powerful drug which 
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Objective: To investigate the antileishmanial, antimicrobial and antimalarial activities of the 
pure metabolites from Jatropha multifida used in African ethnomedicine.
Methods: The methanolic stem bark extract of Jatropha multifida used in Nigerian folk medicine 
as remedy against bacterial infections was subjected to column chromatography and HPLC 
analyses to obtain three known metabolites, microcyclic lathyrane diterpenoids (1-3). Structures 
were confirmed by comparison of 1D and 2D spectral data with literature. 
Results: The three compounds exhibited inhibition of antileishmanial, antimalarial and 
antimicrobial actions against the tested organisms with compouds 2 and 3 active against 
Cryptococcus neoformans at IC50 of 8.2  and 8.7 µg/mL, respectively.
Conclusions: The research lends support to the ethnomedicinal use of the plant in combating 
microbial infections, leishmaniasis and malarial infections.
Peer reviewer
Dr. rer. nat. Iftikhar Ali, Assistant 
Professor, Department of Chemistry, 
Karakoram International University, 
15100 Gilgit-Baltistan, Pakistan.
Tel: +92 333 9665739
Fax: +92 5811 960039
E-mail: iftikhar.ali@kiu.edu.pk 
Comments
As a whole this is a good study to 
unveil the medicinal value of the 
plant, J. multifida that has been 
reported to exhibit high medicinal 
value especially against leishmaniasis. 
Moreover the known metabolites, 
microcyclic lathyrane diterpenoids, 
multifidone and multifidinol that are 
isolated from the plant have exhibited 
inh ib i t i on  o f  an t i l e i shmania l , 
antimalarial and antimicrobial actions 
against the tested organisms. Such 
class of compounds has been proved 
to be promising antileishmanial and 
antimalarial agents.
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have stood the test of time and modern chemistry has 
not been able to replace most of them. The World Health 
Organization reported that 80% of the world’s population 
rely chiefly on traditional medicine and a major part of 
the traditional therapies involve the use of plant extracts 
or their active constituents[1]. Due to the indiscriminate 
use of antimicrobial drugs the microorganisms have 
developed resistance to many antibiotics. This has created 
immense clinical problems in the treatment of infectious 
diseases[2]. In addition to this problem, antibiotics are 
sometimes associated with adverse effects on host which 
include hyper sensitivity, depletion of beneficial gut and 
mucosal microorganisms, immunosuppression and allergic 
reactions[3]. Therefore there is a need to develop alternative 
antimicrobial drugs for the treatment of infectious diseases. 
One approach is to screen local medicinal plants for possible 
antimicrobial properties.
   Malaria is the major tropical disease due to parasites, 
responsible for significant morbidity and mortality in the 
world. A dramatic recrudescence of malaria is ongoing 
due to the increasing resistance of vectors to insecticides 
and the progressive resistance of the parasite, mainly 
Plasmodium falciparum (P. falciparum), to drugs. These 
developments and the difficulty of creating efficient 
vaccines underline the urgent need for new antimalarial 
drugs. In endemic countries, accessible treatments 
against malaria are mainly based on the use of traditional 
herbal remedies. Indeed, indigenous plants play an 
important role in the treatment of many diseases and 
80% of people worldwide are estimated to use herbal 
remedies[4]. P. falciparum is responsible for more than 200 
million episodes of clinical malaria, mostly from tropical 
and subtropical zones, and results in over one million 
deaths per year in Africa[5]. Malaria causes high mortality 
and morbidity in tropical regions of Africa, Asia and 
South America[6]. Natural products from plants or other 
organisms, represent a virtually inexhaustible reservoir 
of molecules, most of which are hardly explored and can 
constitute lead molecules for new antimalarial drugs, such 
as artemisinin, initially isolated from Artemisia annua[7].
   Leishmaniasis is a major public health problem and it 
can cause many different clinical manifestations in humans. 
It is caused by Trypanosomatidae of the Leishmania genus 
spread in Africa, Asia, Europe, North and South America. 
It has been estimated that 12 million people are infected 
in the tropical and subtropical areas of five continents, 
and that 2 and 0.5 million cases of cutaneous and visceral 
leishmaniasis are reported each year[8]. The lack of an 
effective anti-leishmanial drug has led to a renewed 
interest in the study of traditional remedies as sources for 
the development of new chemotherapeutic compounds with 
better activity and less toxic effects. The drugs currently 
used for the treatment of leishmaniasis are still based 
on pentavalent antimonials as sodium stibugluconate 
(Pentostam襆) and meglumine antimoniate (Glucantime襆
). However, these drugs are relatively toxic and expensive 
and the treatment duration is usually long and unbearable. 
Furthermore, resistance to these compounds was observed. 
Quite a lot of funds and resources have gone into the search 
of novel leads from natural products with emphasis on 
medicinal plants for combating them. 
   In our search for hepatitis C virus inhibitors rRNA 
inhibitors and antileshmanial agents from traditional 
medicines, we investigated extracts and fractions of Jatropha 
multifida (J. multifida) from five different traditional 
Nigerian medicines. J. multifida is used in Nigerian folk 
medicine for the treatment of parasitic infections, cancer 
and hepatitis[9]. It is worthy to note that traditional medical 
practitioners have achieved success with the use of this 
plant as remedies against hepatitis and leishmaniasis. 
   J. multifida otherwise known as coral bush is a fast 
growing evergreen shrub or small tree belonging to the 
Euphorbiaceae family. The roots, stems, leaves, seeds 
and oil of the plant have been widely used in African folk 
medicine for the treatment of oral candidiasis, gonorrhoea, 
fever, astriction, wounds and skin infections[10-12].
2. Materials and methods
2.1. Plant materials
   Fresh stem bark of J. multifida was collected from Edo 
State, Nigeria between January and June, 2013. It was 
identified and authenticated by Mr. Ugbogu OA and Shasanya 
OS of the Forest Research Institute of Nigeria (FRIN), Ibadan 
where voucher specimen FHI 93265 is deposited in the 
herbarium. 
2.2. Extraction and isolation
   The powdered stem bark (100 g) material was extracted 
with 500 mL methanol for 48 h (3伊) by cold maceration, 
filtered and the filtrate was evaporated to dryness under 
reduced pressure to obtain the crude extract of J. multifida. 
The total extract was subjected to VLC with hexane: 
ethylacetate 50%, ethylacetate 100%, ethylacetate: methnol 
50%, and methanol 100%. The hexane: ethylacetate fraction 
(3 g) was chromatographed on LH-20 sephadex eluting with 
dichloromethane: methanol (1:1) isocratically to obtain 
fraction A1 to A23. Fractions A1 to A5 was further purified by 
reversed-phase high performance liquid chromatography 
(diameter, 10 mm 伊 length, 250 mm, 10 µm) eluted with 
CH3OH: H2O (60:40) to afford compounds 2 (tR 4.3 min, 6 mg) 
and 3 (tR 6 min, 4 mg). Compound 1 (9 mg) was obtained 
as colourless oil in fraction A10. The chemical structures 
of compounds 1, 2 and 3 were established by 2D nuclear 
magnetic resonance data and comparison of their spectral 
data with previously reported literature.
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2.3. Antimicrobial testing
   In vitro antimicrobial activity against a panel of 
microorganisms, including fungi: Candida albicans (ATCC 
90028), Candida glabrata (ATCC 90030), Candida krusei (ATCC 
6258), Cryptococcus neoformans (ATCC 90113) and Aspergillus 
fumigatus (ATCC 204305) (A. fumigatus); and bacteria: 
Staphylococcus aureus (ATCC 29213) (S. aureus), methicillin-
resistant S. aureus (ATCC 33591), Escherichia coli (ATCC 35218), 
Pseudomonas aeruginosa (ATCC 27853) and Mycobacterium 
intracellulare (ATCC 23068) (M. intracellulare), was determined 
using modified versions of the CLSI/NCCLS methods[13,14]. M. 
intracellulare and A. fumigatus was tested using an Alamar 
Blue method[15]. All organisms were obtained from the 
American Type Culture Collection (Manassas, VA). Samples, 
dissolved in dimethylsulfoxide, were serially diluted in 
saline and transferred in duplicate to 96 well micro plates. 
Susceptibility testing was performed for all organ cate to 
96-well flat bottom micro plates. Microbial inocula were 
prepared by correcting the OD630 of microbe suspensions 
in incubation broth to afford final target inocula. Controls 
[fungi: amphotericin B; bacteria: ciprofloxacin (ICN 
Biomedicals, OH)] were included in each assay. All plates 
were read at 530 or 544 (ex)/590 (em) nm (M. intracellulare and 
A. fumigatus) prior to and after incubation. Percent growth 
was plotted versus test concentration to afford the IC50 using 
XLFit (Alameda, CA). 
2.4. Antimalarial/Parasite lactate dehydrogenase assay 
   The in vitro antimalarial assay procedure utilized was 
an adaptation of the parasite lactate dehydrogenase 
assay[16]. The assay was performed in a 96-well microplate 
and included two P. falciparum clones [Sierra Leone D6 
(chloroquine-sensitive) and Indochina W2 (chloroquine- 
resistant)]. In primary screening the crude plant extracts 
were tested, in duplicate, at a single concentration of 15.9 
íg/mL only on the chloroquine-sensitive (D6) strain of P. 
falciparum. The extract showing >50% growth inhibition of 
the parasite was subjected to screening. For bioassay-guided 
fractionation, the column fractions were also tested only at 
single concentration. The pure compounds were subjected 
to additional testing for determination of IC50 values. The 
standard antimalarial agents chloroquine and artemisinin 
were used as positive controls, with dimethylsulfoxide (0.25%) 
as the negative (vehicle) control. The selectivity indices (SI) 
were determined by measuring the cytotoxicity of samples 
on mammalian cells (VERO; monkey kidney fibroblast). All 
experiments were carried out in duplicate.
 
3. Results
   The 1HNMR-guided fractionation of a methanol extract 
of J. multifida afforded three known compounds 1, 2 and 
3 all of which are macrocyclic lathyrane diterpenoids, 
multifidone and multifidinol respectively. The molecular 
formula of 1 was determined to be C20H30O4 from the HRESIMS 
data, with m/z 357 [M+Na]. The 13CNMR and 1HNMR (Table 1) 
revealed the presence of a lathyrane diterpene in agreement 
with literature report[17]. The presence of the cyclopropane 
moieties in the compounds is diagnostic of the compounds. 
The compound was established as 14-deoxy-1β-hydroxy-
4(4E)-jatrogrossidentadione. Compound 2 was obtained as 
colourless solid, with a molecular formula of C20H32O4 from its 
HRESIMS data. The presence of hydroxyl and carbonyl groups 
in the molecule was diagnosed in infrared radiation. The 
13
CNMR  and 1HNMR (Table 1) also showed the structure to be 
related to the lathyrane diterpenoid. Compound 2 was named 
as 15-deoxy-1β-hydroxy-4(4E)-jatrogrossidentadione 
(Figure 1). Compound 3 was structurally similar to 2 except 
that the ring A of 3 was unsaturated while that of 2 was 
saturated (Figure 1). Compounds 1, 2 and 3 were diterpenoids 
having a lathyrane-diterpenoid skeleton in seco-form. 
Diterpenoids in Jatropha species have been known to 
possess anticancer activity[18,19]. Three metabolites are 
known compounds.
Table 1
1
HNMR and 13CNMR spectral (CDCl3, 400 MHz) data of compounds 1-3.
Compound 1 Compound 2 Compound 3
Position 1HNMR 13CNMR 1HNMR 13CNMR 1HNMR 13CNMR
1 6.70 155.5 1.90, 1.63  42.0 5.40 128.6
2 - 143.8 1.94  40.4 148.6
3 - 195.7 4.04  82.9 4.90   80.2
4 - 137.6 145.3 145.4
5 6.55 141.8 5.68 134.6 6.40 136.8
6 -   74.6   74.5   74.6
7 2.15   42.7 1.82   41.6 1.82   42.1
1.79
1.80 1.60 1.79   19.4
8 1.84   20.6 1.54   19.5 0.80
1.68 0.83 0.44
9 0.96   26.2 0.46   27.3   27.5
0.44   17.1
10 -   17.0   17.8 0.64   19.4
11 1.16   21.5 0.64   19.3 1.79   28.5
1.52   24.8 1.73   28.4
1.13 1.43
13 1.70   30.5 3.06   38.9 2.84   38.6
14 3.84   81.4 210.6 211.6
15 -   79.8   84.6   88.8
16 1.86   10.4 1.22   17.2 1.96   13.9
17 1.40   29.3 1.26   29.8 1.28   29.4
18 0.99   28.5 0.98   28.5 0.99   29.9
19 o.69   14.3 0.72   14.6 0.72   14.6
20 1.21   21.4 1.23   17.2 1.14   16.8
-OH 5.56 - 5.26 5.52
4.14
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H
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Figure 1. Chemical structures of compounds 1-3.
Abiodun Falodun et al./Asian Pac J Trop Biomed 2014; 4(5): 374-378 377
   Compounds 2 and 3 exhibited strong in vitro inhibition 
against P. falciparum at IC50 values ranging from 1 485 and 
47 600 µg/mL. Of the 3 metabolites tested (Table 2), compound 
1 was considered to be the most active against the two clones 
of P. falciparumin culture with IC50 values 7 231.5 µg/mL and 
7 805.6 µg/mL respectively.
   The results of the antimicrobial activity of compounds 1-3 
shown in Table 3 revealed potent activity of compounds 1, 2 
and 3 against the panel of microorganisms used in the study. 
The result of the antileishmanial activity of the compounds 
are presented in Table 4. All the compounds 1-3 were active 
against Leishmania donavoni at the tested concentrations. 
The most potent compound was 2 with IC50 and IC90 of 4.69 
and 6.28 µg/mL, respectively.
Table 2
Activity of metabolites 1-3 against P. falciparum.
Metabolites P. falciparum D6 P. falciparum W2 VERO
 IC50 (µg/mL)  SI  IC50 (µg/mL)  SI
1     7 231.5 >6.6    7 805.6 > 6.1 >47 600
2 >14 875.0 >3.2   25 052.5  >1.9 >47 600
3 >47 600.0   1.0 >47 600.0    1.0 >47 600
Table 3
Antimicrobial activities of metabolites 1-3.
Test organism
IC50 (µg/mL)
1 2 3 Amphotericin  B Ciprofloxacin
CA >200.0 32.2   167.9 0.27 NT
CG   130.5 30.6     23.5 0.39 NT
CK >200.0 15.5 >200.0 0.65 NT
AF >200.0 14.7   155.6 1.18 NT
CN >200.0 8.7      8.2 0.24 NT
SA     34.8 23.6 >200.0 NT 0.120
MRSA     28.4 55.2 >200.0 NT 0.100
EC >200.0 >200.0 >200.0 NT 0.006
PA >200.0 183.5 >200.0 NT 0.090
MI >200.0 >200.0 >200.0 NT 0.400
CA: Candida albicans, CG: Candida glabrata, CK: Candida krusei, AF: A. 
fumigatus, CN: Cryptococcus neoformas, SA: S. aureus, MRSA: methicillin-
resistant S. aureus, EC: Escherichia coli, PA: Pseudomonas aeruginosa, MI: 
M. intracellulare. NT: Not tested.
Table 4
In vitro antileishmenial (Leishmania donovani) activity of metabolites 1-3.
Metabolites Leishmania donavoni Test concentration (µg/mL)
IC50 (µg/mL) IC90 (µg/mL)
1 11.90  22.67 40-1.6
2   4.69   6.22 40-1.6
3   4.56   6.31 40-1.6
Amphotericin B (control)   0.28   0.46 40-1.6
IC50 and IC90 are the sample concentration that kills 50% and 90% cells 
compared to vehicle control.
4. Discussion
   The phytochemical investigation of the stems of J. 
muiltifida led to the isolation of three known constituents 
which were established by the unequivocal 1D and 2D 
NMR experiments. The structures were also identified by 
comparison of data with reported data in literature. Hence, 
the three known diterpenoid compounds possessed a 
lathyrane nucleus. The lathyrane diterpenoids have been 
known to possess a number of interesting biological activities 
such as cytotoxic and anticancer properties. Hence, it 
was considered necessary to subject the compounds to 
antimalarial, antileishmanial and antimicrobial activities.
   The strong inhibition of compound 1 against chloroquine-
sensitive and the chloroquine-resistant P. falciparum 
isolates could be due to the presence of the exo methylene 
group in 1. The highest antifungal activity was consistently 
observed with compounds 2 and 3 (IC50 values of 8.7 and 8.2 
µg/mL respectively) against C. neoformans. A comparison of 
activities of compounds 2 and 3 suggests that the unsaturation 
of the ring A in 3 considerably increases the antifungal 
activity. Compounds 1 and 2 showed marked activity against 
methicillin-resistant S. aureus at IC50 values of 28.4 and 55.2 
µg/mL respectively, suggesting that the lathyrane diterpenoid 
nucleus could be responsible for the antibacterial activity. 
   The preliminary results of this investigation appear to 
indicate that a number of Nigerian medicinal plants have high 
potential of antileishmanial, antimicrobial and antimalarial 
activities.
   This study, to the best of our knownledge is the first 
report of the antileishmanial and antimalarial activities of 
this class of compounds. Further work will be necessary 
to determine in vivo antileishmanial, antimicrobial and 
antimalarial activities, using experimental animals.
   From this study only those compounds that are effective for 
both chloroquine-resistant and chloroquine-sensitive strains 
and which have low IC50 values should be developed further. 
The biological activities lend supports to the ethnomedicinal 
usage of the plant for which they are known and used for.
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Comments 
Background
   The 1HNMR-guided fractionation of the methanolic 
stem bark extract of J. multifida was investigated for 
phytochemicals resulting into the isolation of three known 
metabolites, microcyclic lathyrane diterpenoids, multifidone 
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and multifidinol. The three pure compounds exhibited 
inhibition of antileishmanial, antimalarial and antimicrobial 
actions against the tested organisms. According to the 
authors, this is the first report of the antileishmanial and 
antimalarial activities of this class of compounds.
  
Research frontiers
   The present research work represents the antileishmanial, 
antimalarial and antimicrobial activities of the known 
microcyclic lathyrane diterpenoids isolated and purified 
from the stem bark of Jatropha multifida.
Related reports
   The phytochemical investigation of the stems of J. 
muiltifida led to the isolation of three known constituents 
which were established by the unequivocal 1D and 2D NMR 
experiments. The preliminary results of this investigation 
appear to indicate that a number of Nigerian medicinal 
plants have high potential of antileishmanial, antimicrobial 
and antimalarial activities.
Innovations and breakthroughs
   The traditional Nigerian medicines made of J. multifida, 
are used in Nigerian folk medicine for the treatment of 
parasitic infections, cancer, hepatitis and leishmaniasis. 
According to the authors this is the first report of the 
antileishmanial and antimalarial activities of microcyclic 
lathyrane diterpenoids that are isolated from the plant.
Applications
   According to the literature the roots, stems, leaves, seeds 
and oil of the plant, J. multifida, have been widely used in 
African folk medicine for the treatment of oral candidiasis, 
gonorrhoea, fever, wounds and skin infections, and it is 
also used as purgative. Furthermore the local practitioners 
have achieved success with the use of this plant as 
remedies against hepatitis and leishmaniasis. The present 
experimental results prove the importance of the plant 
against leishmaniasis.
Peer review
   As a whole this is a good study to unveil the medicinal 
value of the plant, J. multifida that has been reported 
to exhibit high medicinal value especially against 
leishmaniasis. Moreover the known metabolites, microcyclic 
lathyrane diterpenoids, multifidone and multifidinol that 
are isolated from the plant have exhibited inhibition of 
antileishmanial, antimalarial and antimicrobial actions 
against the tested organisms. Such class of compounds 
has been proved to be promising antileishmanial and 
antimalarial agents.
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